Surgalign Stock Analysis


USD 4.71  0.03  0.64%   

The current rise in Surgalign Hldg short term price appreciation created some momentum for investors as it was traded today as low as 4.66 and as high as 4.88 per share. The company executives have successfully maneuvered the company at convenient times to take advantage of all market conditions in July. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.53. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Surgalign Hldg partners.
Additionally, take a look at World Market Map.
The Surgalign Hldg stock analysis report makes it easy to digest most publicly released information about Surgalign Hldg and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Surgalign Stock analysis module also helps to analyze the Surgalign Hldg price relationship with some important fundamental indicators such as market cap and management efficiency.

Surgalign Stock Analysis Notes

About 18.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.3. Surgalign Hldg had not issued any dividends in recent years. Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Surgalign Hldg operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 231 people. To find out more about Surgalign Hldg contact the company at 224 303-4651 or learn more at

Surgalign Hldg Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Surgalign Hldg's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Surgalign Hldg or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Surgalign Hldg has very high historical volatility over the last 90 days
The company reported the previous year's revenue of 87.81 M. Net Loss for the year was (65.79 M) with profit before overhead, payroll, taxes, and interest of 62.76 M.
Surgalign Hldg currently holds about 44.68 M in cash with (56.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Surgalign Hldg has a frail financial position based on the latest SEC disclosures
Roughly 18.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Surgalign Hldg exotic insider transaction detected

Surgalign Hldg Upcoming and Recent Events

Earnings reports are used by Surgalign Hldg to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Surgalign Hldg previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report15th of March 2022
Next Financial Report9th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End15th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Surgalign Largest EPS Surprises

Earnings surprises can significantly impact Surgalign Hldg's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Surgalign Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Surgalign Hldg is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Surgalign Hldg backward and forwards among themselves. Surgalign Hldg's institutional investor refers to the entity that pools money to purchase Surgalign Hldg's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares157.8 K539 K
Renaissance Technologies LlcCommon Shares94.5 K322 K
Hightower Advisors LlcCommon Shares84.9 K289 K
Blackrock IncCommon Shares41.5 K141 K
Geode Capital Management LlcCommon Shares34.4 K117 K
Dimensional Fund Advisors LpCommon Shares29.7 K100 K
Ubs Group AgCommon Shares23.4 K80 K
Note, although Surgalign Hldg's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Surgalign Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 680.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Surgalign Hldg's market, we take the total number of its shares issued and multiply it by Surgalign Hldg's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Surgalign Profitablity

Surgalign Hldg's profitability indicators refer to fundamental financial ratios that showcase Surgalign Hldg's ability to generate income relative to its revenue or operating costs. If, let's say, Surgalign Hldg is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Surgalign Hldg's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Surgalign Hldg's profitability requires more research than a typical breakdown of Surgalign Hldg's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (79.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (63.28) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.63.
Last ReportedProjected for 2022
Return on Investment(541.54) (555.79) 
Return on Average Assets(68.68) (70.49) 
Return on Average Equity(399.17) (409.68) 

Management Efficiency

The entity has return on total asset (ROA) of (26.13) % which means that it has lost $26.13 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (298.87) %, meaning that it created substantial loss on money invested by shareholders. Surgalign Hldg management efficiency ratios could be used to measure how well surgalign hldg manages its routine affairs as well as how well it operates its assets and liabilities. As of August 14, 2022, Return on Investment is expected to decline to -555.79. In addition to that, Return on Average Assets is expected to decline to -70.49. Surgalign Hldg Total Assets are projected to decrease significantly based on the last few years of reporting. The past year's Total Assets were at 123.8 Million. The current year Current Assets is expected to grow to about 152.5 M, whereas Revenue to Assets are forecasted to decline to 0.70.

Technical Drivers

As of the 14th of August 2022, Surgalign Hldg has the Semi Deviation of 5.74, risk adjusted performance of 0.0191, and Coefficient Of Variation of 11698.97. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgalign Hldg, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Surgalign Hldg, which can be compared to its competition. Please validate Surgalign Hldg maximum drawdown, as well as the relationship between the downside variance and skewness to decide if Surgalign Hldg is priced more or less accurately, providing market reflects its prevalent price of 4.71 per share. Given that Surgalign Hldg has jensen alpha of 0.008, we advise you to double-check Surgalign Hldg's current market performance to make sure the company can sustain itself at a future point.

Surgalign Hldg Price Movement Analysis

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Surgalign Hldg price series with the more recent values given greater weights.

Surgalign Hldg Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgalign Hldg insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgalign Hldg's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgalign Hldg insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Surgalign Hldg Predictive Daily Indicators

Surgalign Hldg intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Surgalign Hldg stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Surgalign Hldg Forecast Models

Surgalign Hldg time-series forecasting models is one of many Surgalign Hldg's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Surgalign Hldg's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Surgalign Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Surgalign Hldg stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Surgalign shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Surgalign Hldg. By using and applying Surgalign Stock analysis, traders can create a robust methodology for identifying Surgalign entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin(96.17) (98.70) 
EBITDA Margin(49.71) (51.02) 
Gross Margin 67.10  56.80 
Profit Margin(93.54) (96.00) 
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Surgalign Hldg operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 231 people.

Current Surgalign Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Surgalign analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Surgalign analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Surgalign Hldg current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Surgalign analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Surgalign stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Surgalign Hldg, talking to its executives and customers, or listening to Surgalign conference calls.
Surgalign Analyst Advice Details

Surgalign Stock Analysis Indicators

Surgalign Hldg stock analysis indicators help investors evaluate how Surgalign Hldg stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Surgalign Hldg shares will generate the highest return on investment. By understating and applying Surgalign Hldg stock analysis, traders can identify Surgalign Hldg position entry and exit signals to maximize returns.
Quick Ratio2.66
Fifty Two Week Low2.9500
Revenue Growth-11.50%
Shares Short Prior Month306.62k
Average Daily Volume Last 10 Day151.95k
Average Daily Volume In Three Month103.14k
Shares Percent Shares Out3.16%
Gross Margins68.08%
Short Percent Of Float3.51%
Forward Price Earnings-0.76
Float Shares5.41M
Fifty Two Week High48.6000
Enterprise Value To Ebitda0.22
Fifty Day Average3.7638
Two Hundred Day Average13.1277
Enterprise Value To Revenue-0.13
Additionally, take a look at World Market Map. Note that the Surgalign Hldg information on this page should be used as a complementary analysis to other Surgalign Hldg's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Surgalign Stock analysis

When running Surgalign Hldg price analysis, check to measure Surgalign Hldg's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgalign Hldg is operating at the current time. Most of Surgalign Hldg's value examination focuses on studying past and present price action to predict the probability of Surgalign Hldg's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Surgalign Hldg's price. Additionally, you may evaluate how the addition of Surgalign Hldg to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bond Directory
Find actively traded corporate debentures issued by US companies
CEO Directory
Screen CEOs from public companies around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Surgalign Hldg's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgalign Hldg. If investors know Surgalign will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgalign Hldg listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
31.8 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Surgalign Hldg is measured differently than its book value, which is the value of Surgalign that is recorded on the company's balance sheet. Investors also form their own opinion of Surgalign Hldg's value that differs from its market value or its book value, called intrinsic value, which is Surgalign Hldg's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgalign Hldg's market value can be influenced by many factors that don't directly affect Surgalign Hldg's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgalign Hldg's value and its price as these two are different measures arrived at by different means. Investors typically determine Surgalign Hldg value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgalign Hldg's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.